Adherence to Benzathine Penicillin G Secondary Prophylaxis and Its Determinants in Patients with Rheumatic Heart Disease at a Cardiac Center of an Ethiopian Tertiary Care Teaching Hospital

References

• Carapetis JR, Beaton A, Cunningham MW, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:15084. doi:10.1038/nrdp.2015.84
   PubMed Web of Science ®Google Scholar
• Mendis S, Puska P, Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: World Health Organization; 2011.
   Google Scholar
• Seckeler MD, Hoke TRJC. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3:67–84. doi:10.2147/CLEP.S12977
   PubMedGoogle Scholar
• De Dassel JL, Fittock MT, Wilks SC, et al. Adherence to secondary prophylaxis for rheumatic heart disease is underestimated by register data. PLoS One. 2017;12:e0178264. doi:10.1371/journal.pone.0178264
   Web of Science ®Google Scholar
• Cannon J, Roberts K, Milne C, et al. Rheumatic heart disease severity, progression and outcomes: a multi‐state model. JAHA. 2017;6:e003498. doi:10.1161/JAHA.116.003498
   Web of Science ®Google Scholar
• Barik RJ. Secondary prophylaxis to control rheumatic heart disease in developing countries: put into a cage if can’t be killed. Indian Heart J. 2018;70:907–910. doi:10.1016/j.ihj.2018.01.001
   Google Scholar
• Gemechu T, Mahmoud H, Parry EH, Phillips DI, Yacoub MH. Community-based prevalence study of rheumatic heart disease in rural Ethiopia. Eur J Prev Cardiol. 2017;24:717–723. doi:10.1177/2047487316687104
   PubMed Web of Science ®Google Scholar
• Rémond MG, Coyle ME, Mills JE, et al. Approaches to improving adherence to secondary prophylaxis for rheumatic fever and rheumatic heart disease. Cardiol Rev. 2016;24:94–98. doi:10.1097/CRD.0000000000000065
   Web of Science ®Google Scholar
• Ralph AP, De Dassel JL, Kirby A, et al. Improving delivery of secondary prophylaxis for rheumatic heart disease in a high‐burden setting: outcome of a stepped‐wedge, community, randomized trial. J Am Heart Assoc. 2018;7:e009308. doi:10.1161/JAHA.118.009308
   Web of Science ®Google Scholar
• Holland JV, Hardie K, de Dassel J, et al. Rheumatic heart disease prophylaxis in older patients: a register-based audit of adherence to guidelines. Open Forum Infect Dis. 2018;5:1–7.
   Web of Science ®Google Scholar
• de Dassel JL, de Klerk N, Carapetis JR, et al. How many doses make a difference? An analysis of secondary prevention of rheumatic fever and rheumatic heart disease. J Am Heart Assoc. 2018;7:e010223. doi:10.1161/JAHA.118.010223
   PubMed Web of Science ®Google Scholar
• Stewart T, McDonald R, Currie BJ, et al. Acute rheumatic fever: adherence to secondary prophylaxis and follow up of Indigenous patients in the Katherine region of the Northern Territory. Aust J Rural Health. 2007;15:234–240. doi:10.1111/ajr.2007.15.issue-4
   Web of Science ®Google Scholar
• Musoke C, Mondo CK, Zhang W, et al. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital. CJV Africa. 2013;24:124–129.
   Web of Science ®Google Scholar
• Gasse B, Baroux N, Rouchon B, et al. Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study. BMC Public Health. 2013;13:131. doi:10.1186/1471-2458-13-131
   PubMed Web of Science ®Google Scholar
• Thompson SB, Brown CH, Edwards AM, et al. Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever. JAMAICA Pathog Glob Health. 2014;108:229–234. doi:10.1179/2047773214Y.0000000146
   PubMed Web of Science ®Google Scholar
• Mohammed K, Demissie WR, Gare MB, et al. Adherence of rheumatic heart disease patients to secondary prophylaxis and main reasons for poor adherence at Jimma Medical Center. EJCM. 2019;7:22–27. doi:10.32596/ejcm
   Google Scholar
• Günther G, Asmera J, Parry E. Death from rheumatic heart disease in rural Ethiopia. Lancet. 2006;367:391. doi:10.1016/S0140-6736(06)68128-2
   Web of Science ®Google Scholar
• Engel ME, Haileamlak A, Zühlke L, et al. Prevalence of rheumatic heart disease in 4720 asymptomatic scholars from South Africa and Ethiopia. BMJ Heart. 2015;101:1389–1394. doi:10.1136/heartjnl-2015-307444
   Web of Science ®Google Scholar
• Mulatu H, Woldemichael MA. Prevalence of rheumatic heart disease among primary school students in Mid-Eastern Ethiopia. Biol Syst Open Acces. 2015;5:1–4. doi:10.4172/2329-6577.1000149
   Google Scholar
• Grayson S, Horsburgh M, Lennon D. An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N Z Med J. 2006;113:U2255.
   Google Scholar
• Sial JA, Farman MT, Batra MK, Karim MJ. Adherence to secondary prophylaxis of rheumatic fever in patients with rheumatic heart disease in rural areas. Pak Heart J. 2018;51:243–247.
   Web of Science ®Google Scholar
• Balbaa A, ElGuindy A, Pericak D, et al. An evaluation of secondary prophylaxis for rheumatic heart disease in rural Egypt. GCSP. 2015;40:1–8.
   Google Scholar
• Engelman D, Ah Kee M, Mataika R, et al. Secondary prevention for screening detected rheumatic heart disease: opportunities to improve adherence. Trans R Soc Trop Med Hyg. 2017;111:154–162. doi:10.1093/trstmh/trx035
   Web of Science ®Google Scholar
• Saxena A, Mehta A, Ramakrishnan S. Adherence to benzathine penicillin in children with rheumatic fever/rheumatic heart disease: results from an Indian pediatric RHD registry. JACC. 2015;65:A2019. doi:10.1016/S0735-1097(15)62019-8
   Google Scholar
• Huck DM, Nalubwama H, Longenecker CT, et al. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda. Glob Heart. 2015;10:63–69. doi:10.1016/j.gheart.2014.10.001
   PubMed Web of Science ®Google Scholar
• Tullu MS, Gandhi A, Ghildiyal RG. Benzathine penicillin prophylaxis in children with rheumatic fever (RF)/rheumatic heart disease (RHD): a study of compliance. Al Ameen J Med Sci. 2010;3:140–145.
   Google Scholar
• Culliford-Semmens N, Tilton E, Webb R, et al. Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening. NZ Med J. 2017;130:50.
   Web of Science ®Google Scholar
• Oetzel JG, Lao C, Morley M, et al. Efficacy of an incentive intervention on secondary prophylaxis for young people with rheumatic fever: a multiple baseline study. BMC Public Health. 2019;19:385. doi:10.1186/s12889-019-6695-3
   Web of Science ®Google Scholar
• Farzana K, Faruque MO, Zareen S, et al. Factors affecting therapeutic compliance among the patients with rheumatic heart disease in Bangladesh. Cardiovasc. 2018;10:180–185. doi:10.3329/cardio.v10i2.36289
   Google Scholar
• Engelman D, Mataika RL, Kado JH, et al. Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in Fiji. Trop Med Int Health. 2016;21:1583–1591. doi:10.1111/tmi.12796
   Web of Science ®Google Scholar
• Wyber R, Boyd BJ, Colquhoun S, et al. Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever. Drug DelivTransl Res. 2016;6:572–578.
   Web of Science ®Google Scholar